Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium
暂无分享,去创建一个
M. Yoshiyama | K. Hirata | J. Yoshikawa | I. Toda | H. Yamagishi | K. Takeuchi | Y. Sakanoue | H. Ochi | M. Teragaki | K. Akioka
[1] R. Senior,et al. Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging , 1999, Heart.
[2] M. Yoshiyama,et al. Dobutamine-stress electrocardiographically gated positron emission tomography for detection of viable but dysfunctional myocardium , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[3] S. Nekolla,et al. 99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction: additional value of gated SPECT. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] M. Yoshiyama,et al. Detection of a biphasic response of hibernating myocardium by dobutamine-stress electrocardiography-gated technetium-99m-tetrofosmin single photon emission computed tomography--a case report. , 1999, Japanese circulation journal.
[5] J. Pepper,et al. Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. , 1998, Circulation.
[6] S. Vatner,et al. Hibernating myocardium. , 1998, The New England journal of medicine.
[7] C. Degueldre,et al. Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. , 1997, Journal of the American College of Cardiology.
[8] D. Berman,et al. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. , 1997, Journal of the American College of Cardiology.
[9] W. Smith,et al. Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing. , 1997, Circulation.
[10] N Tonami,et al. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201. , 1997, Journal of the American College of Cardiology.
[11] I Buvat,et al. A "hybrid" method for measuring myocardial wall thickening from gated PET/SPECT images. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] E. Erdmann,et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. , 1996, Journal of the American College of Cardiology.
[13] K. Williams,et al. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. , 1996, Journal of the American College of Cardiology.
[14] J. Taki,et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] D. Berman,et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] R. Pickett,et al. Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[17] G Germano,et al. Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] F J Ten Cate,et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. , 1995, Circulation.
[19] A. Soricelli,et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. , 1995, Circulation.
[20] V. Dilsizian,et al. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. , 1995, Circulation.
[21] W. Zoghbi,et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. , 1995, Circulation.
[22] J. Nuyts,et al. Histological Alterations in Chronically Hypoperfused Myocardium: Correlation With PET Findings , 1994, Circulation.
[23] M. Schwaiger,et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. , 1994, Journal of the American College of Cardiology.
[24] E G DePuey,et al. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] H Feigenbaum,et al. Low‐Dose Dobutamine Echocardiography Detects Reversible Dysfunction After Thrombolytic Therapy of Acute Myocardial Infarction , 1993, Circulation.
[26] F. Smith,et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] A. Lammertsma,et al. A New Strategy for the Assessment of Viable Myocardium and Regional Myocardial Blood Flow Using 15O‐Water and Dynamic Positron Emission Tomography , 1992, Circulation.
[28] S L Bacharach,et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.
[29] P. Rigo,et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. , 1990, Journal of the American College of Cardiology.
[30] P. Marzullo,et al. A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy--results in normal subjects. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] T. Faber,et al. Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. , 1989, Circulation.
[32] M Schwaiger,et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.
[33] G Osakada,et al. Nonuniformity of inner and outer systolic wall thickening in conscious dogs. , 1985, The American journal of physiology.
[34] E. Braunwald,et al. The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.